絞り込み

17084

広告

Prions of yeast as heritable amyloidoses.

著者 Wickner RB , Taylor KL , Edskes HK , Maddelein ML , Moriyama H , Roberts BT
J Struct Biol.2000 Jun ; 130(2-3):310-22.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Laboratory of Biochemistry and Genetics, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, Maryland, 20892-0830, USA.

スターを付ける スターを付ける     (1,527view , 0users)

Full Text Sources

Medical

Molecular Biology Databases

Two infectious proteins (prions) of Saccharomyces cerevisiae have been identified by their unusual genetic properties: (1) reversible curability, (2) de novo induction of the infectious prion form by overproduction of the protein, and (3) similar phenotype of the prion and mutation in the chromosomal gene encoding the protein. [URE3] is an altered infectious form of the Ure2 protein, a regulator of nitrogen catabolism, while [PSI] is a prion of the Sup35 protein, a subunit of the translation termination factor. The altered form of each is inactive in its normal function, but is able to convert the corresponding normal protein into the same altered inactive state. The N-terminal parts of Ure2p and Sup35p (the "prion domains") are responsible for prion formation and propagation and are rich in asparagine and glutamine residues. Ure2p and Sup35p are aggregated in vivo in [URE3]- and [PSI]-containing cells, respectively. The prion domains can form amyloid in vitro, suggesting that amyloid formation is the basis of these two prion diseases. Yeast prions can be cured by growth on millimolar concentrations of guanidine. An excess or deficiency of the chaperone Hsp104 cures the [PSI] prion. Overexpression of fragments of Ure2p or certain fusion proteins leads to curing of [URE3].
PMID: 10940235 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード